In Vivo CRO Market Projected to Reach USD 7.96 Billion by 2030 with Substantial Growth Across Regions and Segments
14 janv. 2025 10h49 HE
|
Research and Markets
Dublin, Jan. 14, 2025 (GLOBE NEWSWIRE) -- The "In Vivo CRO Market Size, Share & Trends Analysis Report By Model Type, By Modality, By Indication, By GLP Type, By Region, And Segment Forecasts,...
Preclinical Contract Research Organizations (CRO) Business Report 2024: Global Market to Reach $11.3 Billion by 2030, Complex Drug Development Spurs Need for Specialized Preclinical Testing
10 janv. 2025 11h06 HE
|
Research and Markets
Dublin, Jan. 10, 2025 (GLOBE NEWSWIRE) -- The "Preclinical Contract Research Organizations - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global...
Oncology Based in-Vivo CRO Business Research Report 2024: Global Market to Reach $2.5 Billion by 2030 - Expansion in Drug Discovery, Translational Research, and Toxicology Fuels Growth
09 janv. 2025 04h01 HE
|
Research and Markets
Dublin, Jan. 09, 2025 (GLOBE NEWSWIRE) -- The "Oncology Based in-Vivo CRO - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for...
Relapsed Multiple Myeloma Clinical Trials Review 2024: Clinical Trials by Region, Country, Trial Status, Trial Phase, Sponsor Type and End Point Status
27 déc. 2024 04h34 HE
|
Research and Markets
Dublin, Dec. 27, 2024 (GLOBE NEWSWIRE) -- The "Relapsed Multiple Myeloma - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.The clinical...
Refractory Multiple Myeloma Global Clinical Trials Review 2024 - Top Level Data on Clinical Trials by Region, Country, Trial Status, Trial Phase, Sponsor Type and End Point Status
27 déc. 2024 04h33 HE
|
Research and Markets
Dublin, Dec. 27, 2024 (GLOBE NEWSWIRE) -- The "Refractory Multiple Myeloma - Global Clinical Trials Review, 2024" has been added to ResearchAndMarkets.com's offering.The clinical trial report...
Preclinical CRO Industry Assessment: Growth Opportunities and Strategies to 2033
11 déc. 2024 07h26 HE
|
Research and Markets
Dublin, Dec. 11, 2024 (GLOBE NEWSWIRE) -- The "Preclinical CRO Market Opportunities and Strategies to 2033" report has been added to ResearchAndMarkets.com's offering.This report describes and...
Pharmaceutical CRO Market Report 2025-2030, Featuring Parexel, ICON, Laboratory Corporation of America, Thermo Fisher Scientific, Medpace, IQVIA, WuXi AppTec and Veeda Clinical Research
03 déc. 2024 05h20 HE
|
Research and Markets
Dublin, Dec. 03, 2024 (GLOBE NEWSWIRE) -- The "Pharmaceutical CRO Market Size, Share & Trends Analysis Report by Type (Drug Discovery, Pre-Clinical, Clinical), Molecule Type (Small Molecules,...
Contract Research Organization (CRO) Services Global Market Report 2024-2029: Increasing Adoption of AI in CROs, Added Efficiency, Inorganic Strategies Fueling Opportunities
22 nov. 2024 04h06 HE
|
Research and Markets
Dublin, Nov. 22, 2024 (GLOBE NEWSWIRE) -- The "Contract Research Organization (CRO) Services: Global Markets" report has been added to ResearchAndMarkets.com's offering.The contract research...
Patient Derived Xenograft (PDX) Models Market Expects Significant Growth, Reaching $710 Million by 2028 - Global Long-term Forecasts to 2033
21 nov. 2024 11h30 HE
|
Research and Markets
Dublin, Nov. 21, 2024 (GLOBE NEWSWIRE) -- The "Patient Derived Xenograft (PDX) Models Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The patient derived...
Biosimilars Market Industry Report 2024 - Rising Demand for Biosimilars as a Cost-effective Alternative has Promoted the Need for Increased In-house Development and Outsourcing Operations
08 nov. 2024 04h37 HE
|
Research and Markets
Dublin, Nov. 08, 2024 (GLOBE NEWSWIRE) -- The "Biosimilars Market Industry Trends and Global Forecasts to 2035 - Distribution by Drug Class, Therapeutic Area, Type of Manufacturer, Distribution...